alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2017424EN.01004001.xml

| 11.12.2017 | EN | Official Journal of the European Union | C 424/40 |
| --- | --- | --- | --- |

11.12.2017

EN

Official Journal of the European Union

C 424/40

---

Action brought on 4 August 2017 — La Guirigaña and Others v ECB and SRB

(Case T-613/17)

(2017/C 424/58)

Language of the case: Spanish

Parties

Parties

Applicants: La Guirigaña, S.L. (Madrid, Spain) and seven other applicants (represented by: J. Díaz-Patón Porras, lawyer)

Applicants:

Defendants: European Central Bank and Single Resolution Board

Defendants:

Form of order sought

Form of order sought

The applicants claim that the General Court should take note that an application has been lodged alleging that the European Union has incurred financial liability in respect of acts and omissions attributable to the European Central Bank and take note of the joint lodging of an action against the Decision of the Single Resolution Board of 7 June 2017 and, following the appropriate legal procedure, should:

| — | Declare that the European Union has incurred financial liability towards the applicants; |
| --- | --- |

—

Declare that the European Union has incurred financial liability towards the applicants;

| — | Annul the Single Resolution Board’s decision of 7 June 2017, depriving it of effect, |
| --- | --- |

—

Annul the Single Resolution Board’s decision of 7 June 2017, depriving it of effect,

| — | In the alternative, should the Court not uphold the aforementioned claims, order that the Single Resolution Board compensate the applicants. |
| --- | --- |

—

In the alternative, should the Court not uphold the aforementioned claims, order that the Single Resolution Board compensate the applicants.

Pleas in law and main arguments

Pleas in law and main arguments

The pleas in law and main arguments are similar to those put forward in Cases T-478/17, Mutualidad de la Abogacía and Hermandad Nacional de Arquitectos Superiores y Químicos v Single Resolution Board, T-481/17, Fundación Tatiana Pérez de Guzmán el Bueno and SFL v Single Resolution Board, T-482/17, Comercial Vascongada Recalde v Commission and Single Resolution Board, T-483/17, García Suárez and Others v Commission and Single Resolution Board, T-484/17, Fidesban and Others v Single Resolution Board, T-497/17, Sáchez del Valle and Calatrava Real State 2015 v Commission and Single Resolution Board, and T-498/17, Pablo Álvarez de Linera Granda v Commission and Single Resolution Board.

Mutualidad de la Abogacía and Hermandad Nacional de Arquitectos Superiores y Químicos

Single Resolution Board

Fundación Tatiana Pérez de Guzmán el Bueno and SFL

Single Resolution Board

Comercial Vascongada Recalde

Commission and Single Resolution Board

García Suárez and Others

Commission and Single Resolution Board

Fidesban and Others

Single Resolution Board

Sáchez del Valle and Calatrava Real State 2015

Commission and Single Resolution Board

Pablo Álvarez de Linera Granda

Commission and Single Resolution Board.

---
Exhibit 32 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)   In connection with the Quarterly Report of Uranium Plus Resource Corp., a Nevada corporation (the Company), on Form 10-Q for the quarter ending June 30, 2008, as filed with the Securities and Exchange Commission (the Report), I, H. James Graham, CEO of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to my knowledge:  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   /s/ H. James Graham H. James Graham CEO, Chief Accounting Officer  Dated:  August 8, 2008
Case 1:07-cv-05804-GEL     Document 8      Filed 11/02/2007     Page 1 of 2

Case 1:07-cv-05804-GEL     Document 8      Filed 11/02/2007     Page 2 of 2
Case 1:07-cr-00568-HBP Document 17 Filed 09/18/2007 Page 1 of 5
Case 1:07-cr-00568-HBP Document 17 Filed 09/18/2007 Page 2 of 5
Case 1:07-cr-00568-HBP Document 17 Filed 09/18/2007 Page 3 of 5
Case 1:07-cr-00568-HBP Document 17 Filed 09/18/2007 Page 4 of 5
Case 1:07-cr-00568-HBP Document 17 Filed 09/18/2007 Page 5 of 5
# C_2019016EN.01004301.xml

| 14.1.2019 | EN | Official Journal of the European Union | C 16/43 |
| --- | --- | --- | --- |

14.1.2019

EN

Official Journal of the European Union

C 16/43

---

Judgment of the General Court of 14 November 2018 — Foodterapia v EUIPO — Sperlari (DIETOX)

(Case T-486/17) (1)

((EU trade mark - Opposition proceedings - Application for EU figurative mark DIETOX - Earlier EU figurative mark Dietor - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001)))

(2019/C 16/52)

Language of the case: English

Parties

Applicant: Foodterapia, SL (Barcelona, Spain) (represented by: J.C. Erdozain López, J. Galán López and H. Tellez Robledo, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Sperlari Srl, formerly Cloetta Italia Srl (Cremona, Italy) (represented by: P. Pozzi and G. Ghisletti, lawyers)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 12 May 2017 (Case R 1611/2016-5), concerning opposition proceedings between Cloetta Italia and Foodterapia.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Foodterapia, SL, to bear its own costs and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and by Sperlari Srl, including the costs necessarily incurred by the latter’s legal predecessor before the Board of Appeal of EUIPO. |
| --- | --- |

2.

Orders Foodterapia, SL, to bear its own costs and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and by Sperlari Srl, including the costs necessarily incurred by the latter’s legal predecessor before the Board of Appeal of EUIPO.

---

(1)  OJ C 318, 25.9.2017.

---
Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk December 21, 2009

p1214 

# Order

December 21, 2009

139583

CITIZENS INSURANCE COMPANY OF AMERICA, Plaintiff-Counter-DefendantAppellee,

v SC: 139583 COA: 283557 Charlevoix CC: 99-184718-CK FRANCIS LADI, LAURA WILSON, MARK SOKOLOWSKI and LISA SOKOLOWSKI, CHARLES CRADDUCK and DIANA CRADDUCK, DEBORAH YAGER, MARK YAGER ESTATE , MEGAN YAGER, MARK YAGER, KATIE YAGER, EMILY YAGER, MARCELLA YAGER, TADEUSZ DOBROWOLSKI, JANET DOBROWOLSKI, CHRISTOPHER DOBROWOLSKI, ADAM DOBROWOLSKI, KYLE DOBROWOLSKI, RICHARD DAVIS, SECOND CHANCE, FIREWORKS NORTH, INC, MICHAEL JAY, GLENN CRAWFORD, LAWRENCE GRISE and DENNIS HALVERSON, Defendants,

and

AUTO OWNERS INSURANCE CO, Intervening-Counter-Plaintiff- Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the July 21, 2009 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 201 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 201

     Recognizing the National Comedy Center in Jamestown, New York.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 3, 2019

   Mr. Reed introduced the following bill; which was referred to the 
                     Committee on Natural Resources

_______________________________________________________________________

                                 A BILL

 
     Recognizing the National Comedy Center in Jamestown, New York.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``National Comedy Center Recognition 
Act''.

SEC. 2. DESIGNATION OF NATIONAL COMEDY CENTER IN JAMESTOWN, NEW YORK.

    (a) Congressional Recognition.--Congress--
            (1) recognizes that the National Comedy Center, located in 
        Jamestown, New York, is the only museum of its kind that exists 
        for the exclusive purpose of celebrating comedy in all its 
        forms; and
            (2) officially designates the National Comedy Center as the 
        National Comedy Center.
    (b) Effect of Recognition.--The National Comedy Center recognized 
in this section is not a unit of the National Park System, and the 
designation shall not be construed to require or permit Federal funds 
to be expended for any purpose related to the Center.
                                 <all>
```
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned operating manager of NGA HoldCo, LLC (the Company) hereby certifies to
his knowledge that the Companys quarterly report on Form 10-QSB for the period ended September 30, 2007 (the Report), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the
requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.



|                        |  |  |  |                                                               
|----------------------- |  |  |  | --------------------------------------------------------------
|                        |  | 
|Date: November 14, 2007 |  |  |  | /s/ Thomas R. Reeg                                            
|                        |  |  |  | Thomas R. Reeg Operating Manager (Principal Executive Officer)
ICE Swap Trade LLC

55 East 52nd Street

New York, NY 10055

November 3, 2020

Submitted via the CFTC Portal Submission 20-05

Melissa Jurgens

Office of the Secretariat

U.S. Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

via email: submissions@cftc.gov

Re: ICE Swap Trade, LLC – Regulation §40.6 Self-Certification of Rules – Post Trade Name 

Give-Up Rule

Ladies and Gentlemen:

Pursuant to Section 5c(c) of the Commodity Exchange Act (the “Act”) and Section 40.6(d) of the 

regulations of the Commodity Futures Trading Commission (the “Commission”), ICE Swap Trade, 

LLC (“IST” or the “SEF”) hereby notifies the Commission that it has amended its Rulebook. The 

amended Rulebook will become effective on November 18, 2020. Please find enclosed two 

versions of the Rulebook, a clean version and a marked version showing amendments.

A concise explanation and analysis of the amendments to the Rulebook and their compliance 

with applicable provisions of the Act, including core principles and the Commission’s regulations, 

is attached hereto as Exhibit A. A clean copy of the amended Rulebook is attached hereto as 

Exhibit B, and a copy of the amended Rulebook marked to show changes against the previous 

version, which became effective August 17, 2020, is attached hereto as Exhibit C.

IST certifies that the amendments comply with the requirements of the Commodity Exchange Act 

and the rules and regulations promulgated thereunder. IST is not aware of any substantive 

opposing views expressed with respect to this filing and certifies that, concurrent with this filing, 

a copy of this submission was posted on the IST’s website and may be accessed at: 

https://www.theice.com/swap-trade/regulation#rule-filings.

Please contact the undersigned at (212) 323-8543 with any questions regarding this matter.

Very truly yours,

Robert J. Laorno

General Counsel

Enclosure
Exhibit A

Summary of Rulebook Changes

Amendment Explanation

Definitions Added “Executed Anonymously”

Definitions Edited the No-Action Relief to 2020 updated guidance 

Chapter 5

Rule 514

Split Rule 514 into ‘A’ and ‘B’ and added Post Trade Name Give Up provision
ex10-4.htm




Exhibit 10.4







Compensation for Named Executive Officers


for Fiscal 2011













	
Name (1)

	
Principal Position

	
Annual Base Salary

	
Annual Cash Bonus


	
C. Larry Pope

	
President and Chief Executive Officer

	
$ 1,100,000

	
(2)


	
Robert W. Manly, IV

	
Executive Vice President and Chief Financial Officer

	
$    600,000

	
(3)


	
George H. Richter

	
President and Chief Operating Officer, Pork Group

	
$    850,000

	
(4)


	
Jerry H. Godwin

	
President of Murphy-Brown

	
$    750,000

	
(5)







 








 


(1)       Richard J.M. Poulson, who was a Named Executive Officer of the Company for fiscal 2010, recently retired from the Company effective September 1, 2010.  The specifics of his Retirement Agreement and General Release, dated as of August 9, 2010, were set forth in the Company’s Current Report on Form 8-K filed with the SEC on August 16, 2010. The annual base salary and annual cash bonus formula for fiscal 2011 for Mr. Poulson were unchanged from fiscal 2010.







(2)       The bonus formula for Mr. Pope is:


•     0% of the first $100 million of Company net profits before taxes and management incentivepayments (“Company net profits”),


•     1.5% of Company net profits in excess of $100 million and less than $400 million, and


•     2% of Company net profits in excess of $400 million.








	
(3)

	
The bonus formula for Mr. Manly is:







•     0% of the first $100 million of Company net profits,


•     0.5% of Company net profits in excess of $100 million and less than $400 million, and


•     0.75% of Company net profits in excess of $400 million.







(4)       Mr. Richter will not earn any bonus if the consolidated pretax profits of the Pork Group after all expenses and accruals, including bonuses, charges and credits (the “Pork Group net profits”) is less than $300 million.  If the Pork Group net profits exceed $300 million, Mr. Richter’s bonus will equal $500,000 plus 0.75% of Pork Group net profits in excess of $300 million.


 


(5)       The bonus formula for Mr. Godwin is:


•     0% of the first $50 million of the consolidated pretax profits of Murphy-Brown LLC, including the Company’s percentage interest in Butterball LLC, after all expenses and accruals, including bonuses, charges and credits (“Murphy-Brown net profits”),


•     0.5% of Murphy-Brown net profits in excess of $50 million and less than $100 million, and


•     1.0% of Murphy Brown net profits in excess of $100 million.
Exhibit 32.2








CERTIFICATION





Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, the undersigned officer of TheraBiogen, Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:





(1)    The quarterly report on form 10-Q of the Company for the annual period ended August 31, 2011 (“the Report”) fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and





(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




Dated: October 17, 2011
By:
/s/ Mark D. ShoomanMark D ShoomanChief Financial Officer





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
January 24, 2024

VIA CFTC PORTAL 

Commodity Futures Trading Commission

Attention: Chris Kirkpatrick, Secretary

Three Lafayette Centre

1155 21st Street, NW

Washington, DC 20581

Re: CFTC Regulation 40.6(a) Certification: Amendments to Nodal Clear Risk Policies and Risk 

Management Framework

Dear Mr. Kirkpatrick:

Pursuant to Commodity Futures Trading Commission (“Commission” or “CFTC”) Regulation 40.6(a), Nodal Clear, LLC 

(“Nodal Clear” or “Clearing House”) hereby notifies the Commission that it is self-certifying amendments to the Nodal 

Clear Risk Policies ("Risk Policies") and Risk Management Framework (“Risk Management Framework”). The Risk

Policies and Risk Management Framework are attached hereto with indications as to the specific text that is being 

amended. Amendments to the Risk Policies and Risk Management Framework are to be effective on February 7, 2024.

Nodal Clear has enhanced its Risk Policies and Risk Management Framework in the course of improving Nodal Clear’s 

risk management practices. 

Nodal Clear management has assessed the amendments to the Risk Policies and Risk Management Framework and 

their compliance with applicable provisions of the Commodity Exchange Act (“CEA”), including the Commission’s 

Regulations and DCO Core Principles. Nodal Clear has identified that the amendments may have some bearing on 

the following Core Principles:

Core Principle B – Financial Resources: The amendments to the Risk Policies and Risk Management Framework 

continue to ensure Nodal Clear’s ability to discharge its financial, operational, and managerial responsibilities as a DCO.

Core Principle D – Risk Management: The amendments to the Risk Policies and Risk Management Framework

continue to ensure Nodal Clear’s ability to identify and manage the risks associated with discharging the responsibilities 

of a DCO.

Pursuant to Section 5c(c)(1) of the CEA and the Commission’s Regulation 40.6(a), Nodal Clear certifies that the 

amendments to the Risk Policies and Risk Management Framework comply with the CEA and the Commission’s 

Regulations thereunder. Nodal Clear is not aware of any opposing views expressed regarding the amendments to the 

Risk Policies or Risk Management Framework. Nodal Clear certifies that this submission has been concurrently posted 

on the Nodal Clear website at www.nodalclear.com.

If you have any questions or need additional information regarding this submission, please contact me at 703-962-9864 

or alvarez@nodalexchange.com. 

Sincerely,

/s/Cody Alvarez

Cody Alvarez

Chief Compliance Officer

Corporate Counsel
Attachments:

Nodal Clear Risk Policies Redline (confidential treatment requested)

Nodal Clear Risk Management Framework Redline (confidential treatment requested)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel.                    

*Date:*                         May 15, 2001.                    

*Time:*                         11 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         NIH, Rockledge 2, Bethesda MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Samuel Rawlings, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5160, MSC 7844, Bethesda, MD 20892, (301) 435-1243.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine, 93.306; 93.333, Clinical Research, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: May 9, 2001.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 01-12471  Filed 5-16-01; 8:45 am]

BILLING CODE 4140-01-M